
FOLLOWUS
The First Affiliated Hospital of Xi’an Medical University,Xi’an
Published:1999,
Scan for full text
Hao, Y., Sun, X. & Zhang, J. Effect of Yunqi decoction on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients) on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients., CJIM 5, 32–35 (1999). https://doi.org/10.1007/BF02934186
Yaning Hao, Xicai Sun, Jian Zhang. Effect of Yunqi decoction on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients) on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients. [J]. Chinese Journal of Integrative Medicine 5(1):32-35(1999)
Hao, Y., Sun, X. & Zhang, J. Effect of Yunqi decoction on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients) on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients., CJIM 5, 32–35 (1999). https://doi.org/10.1007/BF02934186 DOI:
Yaning Hao, Xicai Sun, Jian Zhang. Effect of Yunqi decoction on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients) on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients. [J]. Chinese Journal of Integrative Medicine 5(1):32-35(1999) DOI: 10.1007/BF02934186.
Objective: To observe the effects of Yunqi decoction (
YQD) on both esophageal mucosal morphology and esophageal motility in patients with reflux esophagitis (RE).Methods: According to syndrome differentiation of traditional Chinese medicine (TCM)
42 RE patients were divided into three groups: disharmony of Liver and Stomach (group D)
Deficiency-Cold of Spleen and Stomach (Group DC)
Heat Syndrome caused by stagnation of Liver Qi (Group H). No. I
II
III of YQD were taken respectively for 4 weeks. Before and after treatment scores of typical symptoms were collected
gastroscopy was performed and esophageal motility were measured.Results: (1) The symptom remission rate was 81.1%
there were significant differences between the group DC with group D and group H(P < 0.01). (2) The esophageal mucosal healing rate was 61.9%
the effective rate was 90.5%
and the ineffective rate was 9.5%. There were not significant differences of effective rate among the three groups (P>0.05). (3) The changes of esophageal motility: Lower esophageal sphincter pressure (LESP) and average peristaltic pressure (APP) of group D were obviously higher than before treatment (P < 0.05)
LESP
gastro-esophageal barrier pressure (GEBP) and peristaltic conduct speed (PCS) of group DC were remarkably higher (P < 0.05). GEBP of group H was improved (P < 0.05). Conclusions: YQD has a good therapeutic effect. It’s not only resolving reflux esophageal symptoms
healing esophageal mucosa
but also improving esophageal motile function.
Objective: To observe the effects of Yunqi decoction (
YQD) on both esophageal mucosal morphology and esophageal motility in patients with reflux esophagitis (RE).Methods: According to syndrome differentiation of traditional Chinese medicine (TCM)
42 RE patients were divided into three groups: disharmony of Liver and Stomach (group D)
Deficiency-Cold of Spleen and Stomach (Group DC)
Heat Syndrome caused by stagnation of Liver Qi (Group H). No. I
II
III of YQD were taken respectively for 4 weeks. Before and after treatment scores of typical symptoms were collected
gastroscopy was performed and esophageal motility were measured.Results: (1) The symptom remission rate was 81.1%
there were significant differences between the group DC with group D and group H(P < 0.01). (2) The esophageal mucosal healing rate was 61.9%
the effective rate was 90.5%
and the ineffective rate was 9.5%. There were not significant differences of effective rate among the three groups (P>0.05). (3) The changes of esophageal motility: Lower esophageal sphincter pressure (LESP) and average peristaltic pressure (APP) of group D were obviously higher than before treatment (P < 0.05)
LESP
gastro-esophageal barrier pressure (GEBP) and peristaltic conduct speed (PCS) of group DC were remarkably higher (P < 0.05). GEBP of group H was improved (P < 0.05). Conclusions: YQD has a good therapeutic effect. It’s not only resolving reflux esophageal symptoms
healing esophageal mucosa
but also improving esophageal motile function.
reflux esophagitisesophageal motilityYunqi decoctionSyndrome Differentiation in traditional Chinese medicine
reflux esophagitisesophageal motilityYunqi decoctionSyndrome Differentiation in traditional Chinese medicine
Savary M, Miller G. The esophagus. Hand book and atlas of endoscopy. Soveure Switzerland: Gassman AG, 1978: 135–142.
Singleton JW. 1983; 3(3): 178.
1993: 376.
1991;11(3): 144.
Ke MY, Pan GZ. Diagnosis of gastroesophageal reflux disease in China. Gastroenterol Hepatol 1991; 6(Supple 2): 4.
1986: 33.
1981: 294.
1992; 14(5): 15.
1992; (2): 36.
Hetlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Scand J Gastroenterol 1993; 28(3): 224.
Inauen W, Emde C, Weber B, et al. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: A 24 hour ambulatory combined pH and manometry study. Gut 1993;34(8): 1025–1031.
0
Views
358
Downloads
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621